SCHEMBL7970737

SCHEMBL7970737

OCc1ccccc1Sc1ccccc1CNc1nc2ccccc2n2cncc12

nearest known ligand 0.55

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7986755 0.80 LCK (0.63) LCK
SCHEMBL7980569 0.79 KDM4E (0.65) LCK
SCHEMBL7981693 0.76 LCK (0.66) LCK
SCHEMBL7980641 0.76 LCK (0.67) LCK
SCHEMBL7969734 0.73 LCK (0.58) LCK
SCHEMBL7987006 0.72 LCK (0.64) LCK
SCHEMBL7980128 0.71 EED (0.61) LCK
SCHEMBL7969596 0.71 LCK (1.00) LCK
SCHEMBL31500073 0.70 LCK (0.61) LCK
SCHEMBL7979848 0.70 LCK (0.58) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed